Skip to content
Innovative Tech
Diseases
Health Policy
HTA
Data Analysis
Clinical Practice
Contributors
BACK TO MAIN SITE
Impending Net Drug Price Transparency Regulatio...
By
Rene Pretorius
June 27, 2025
A new CMS rule to force drug price transparency is poised to reshape the pharmaceutical and healthcare landscape. With regulat...
How Does Mind’s AI-Driven Mental Healthcare Transform Care?
Transparency in Industry Partnerships: Building Trust
DALY Modeling Methods for Enhanced Health Economics and Policy Analysis
Pharmaceutical Pricing Issues: Beyond Overpricing and Profit Motives
Cell Therapy for Type 1 Diabetes: Vertex Trial Results and Market Potential
Biosimilar Clinical Approach
FDA Approval and Access Strategy for Lenacapavir (Yeztugo) Long-Acting HIV Pr...
Canada Launches Consultation for Essential Prescription Drugs List
ACIP Vaccine Policy Concerns
NICE Rejects Donanemab: Treatment Cost-Effectiveness
Efficacy of Ultomiris Pediatric TMA Treatment
How Gene-Editing Therapies Are Revolutionizing ASCVD Treatment and Market Tra...
« Previous
1
…
23
24
25
26
27
…
94
Next »